Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-002285-76Phase 3Completed
Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Liraglutide + insulin pump with Placebo + insulin pump (2 arms). Primary endpoint: Change in HbA1c. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-002285-76.